Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Privacy & Cookies

We use cookies and similar technologies

ResearchHub uses necessary technologies for security, authentication and core functionality. Advertising choices, where available, are collected separately through Google's consent message.

See our Privacy Notice and Cookie Policy.

Cancer Immunology, Immunotherapy - ResearchHub

Journal

Cancer Immunology, Immunotherapy

0340-7004 · Springer Science and Business Media LLC

105 verified public works

Browse all journals →

Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells

1994 · 0 citations

Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131 I-labeled Hepama-1 mAb. Preliminary results and discussion

1994 · 0 citations

Analysis of T cell receptor ?? variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions

1994 · 0 citations

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies

1994 · 0 citations

Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells

1994 · 0 citations

Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro

1994 · 0 citations

Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection

1994 · 0 citations

Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients

1994 · 0 citations

Non-fastidious, melanoma-specific CD8 + cytotoxic T lymphocytes from choroidal melanoma patients

1994 · 0 citations

In vivo regulation of transforming growth factor ?1 transcription by immunotherapy: interleukin-2 impairs interferon-?-stimulated increase in steady-state mRNA levels of transforming growth factor ?1

1994 · 0 citations

Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon ? in hairy-cell leukemia patients

1994 · 0 citations

Combined activation of murine lymphocytes with staphylococcalenterotoxin and interleukin-2 results in additive cytotoxic activity

1994 · 0 citations

Reduced expression of distinct T-cell CD moleculesby collagenase/DNase treatment

1994 · 0 citations

Elimination of CD4 + T cells in micebearing an advanced sarcoma augmentsthe antitumor action of interleukin-2

1994 · 0 citations

Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas

1994 · 0 citations

PreviousPage 4 of 4